Icahn School of Medicine At Mount Sinai — New York, New York

Icahn School of Medicine At Mount Sinai is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Icahn School of Medicine At Mount Sinai has participated in 15 clinical trials with 10 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Unresectable Cholangiocarcinoma.

Sponsors: BeiGene, Incyte Corporation, Arbor Research Collaborative for Health.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine At Mount Sinai?

Icahn School of Medicine At Mount Sinai has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine At Mount Sinai conducted?

Icahn School of Medicine At Mount Sinai has 15 clinical trials on record, with 10 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Unresectable Cholangiocarcinoma.

Is Icahn School of Medicine At Mount Sinai accredited by Crixeo Health?

Yes — Icahn School of Medicine At Mount Sinai holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Icahn School of Medicine At Mount Sinai?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.